Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan (Q40043301)

16 September 2017

title

Effectiveness of Vi capsular polysaccharide typhoid vaccine among children: a cluster randomized trial in Karachi, Pakistan (English)

1 reference

16 September 2017

1 reference

1 reference

randomized experiment

1 reference

based on heuristic

inferred from title

cluster randomized trial

1 reference

1 reference

9

Zulfiqar A Bhutta

1 reference

16 September 2017

8

John D Clemens

1 reference

16 September 2017

3

R Leon Ochiai

1 reference

16 September 2017

M Imran Khan

1

1 reference

16 September 2017

Sajid Bashir Soofi

2

1 reference

16 September 2017

Mohammad Atif Habib

4

1 reference

16 September 2017

Shah Muhammad Sahito

5

1 reference

16 September 2017

S Qamaruddin Nizami

6

1 reference

16 September 2017

Camilo J Acosta

7

1 reference

16 September 2017

DOMI Typhoid Karachi Vi Effectiveness Study Group

10

1 reference

16 September 2017

language of work or name

English

0 references

publication date

18 June 2012

1 reference

16 September 2017

1 reference

16 September 2017

volume

30

1 reference

16 September 2017

issue

36

1 reference

16 September 2017

page(s)

5389-5395

1 reference

Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trial

16 September 2017

uses

randomized experiment

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Safety and immunogenicity of two Salmonella typhi Vi capsular polysaccharide vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Protective activity of Vi capsular polysaccharide vaccine against typhoid fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Direct and indirect effects in vaccine efficacy and effectiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

A study of typhoid fever in five Asian countries: disease burden and implications for controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Enhanced disease surveillance through private health care sector cooperation in Karachi, Pakistan: experience from a vaccine trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Comparative tolerability and immunogenicity of Typherix or Typhim Vi in healthy adults: 0, 12-month and 0, 24-month administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Simple sample size calculation for cluster-randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Longitudinal data analysis for discrete and continuous outcomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Reactogenicity and immunogenicity of a single dose of typhoid Vi polysaccharide vaccine in children aged between 4 and 14 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

Control of typhoid fever in Bangkok, Thailand, by annual immunization of schoolchildren with parenteral typhoid vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.015

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2012.06.015

1 reference

16 September 2017

1 reference